Loading...
Loading...
Indian Pharmaceutical Exporter Β· #10 for Nitrofurantoin Β· $525.4K export value Β· DGFT Verified
Aurobindo Pharma Limited is the #10 Indian exporter of Nitrofurantoin with $525.4K in export value and 12 verified shipments. Aurobindo Pharma Limited holds a 1.5% market share in Nitrofurantoin exports across 4 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.

| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $201.6K | 12 | 30.4% |
| UNITED STATES | $149.4K | 6 | 22.5% |
| MALTA | $145.9K | 10 | 22.0% |
| SOUTH AFRICA | $117.0K | 7 | 17.6% |
| CANADA | $50.0K | 1 | 7.5% |
Aurobindo Pharma Limited exports Nitrofurantoin to 5 countries. The largest destination is UNITED KINGDOM accounting for 30.4% of Aurobindo Pharma Limited's Nitrofurantoin shipments, followed by UNITED STATES (22.5%) and MALTA (22.0%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $145.9K | 10 |
| ALLOGA UK | UNITED KINGDOM | $95.2K | 5 |
| AUROGEN SOUTH AFRICA (PTY) LTD, | SOUTH AFRICA | $74.4K | 3 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $69.7K | 2 |
| XXRO XXARMXXINC | CANADA | $50.0K | 1 |
| AUROLOGISTICS LLC | UNITED STATES | $50.0K | 1 |
India exported $20.2M worth of Nitrofurantoin through 1,809 shipments from 199 suppliers to 92 countries, serving 317 buyers globally. Aurobindo Pharma Limited contributes $525.4K to this total, accounting for 1.5% of India's Nitrofurantoin exports. Aurobindo Pharma Limited ships Nitrofurantoin to 5 countries through 14 buyers.
Aurobindo Pharma Limited's average Nitrofurantoin shipment value is $43.8K per consignment, based on 12 shipments totaling $525.4K. The largest destination is UNITED KINGDOM (30.4% of Aurobindo Pharma Limited's Nitrofurantoin exports).
Aurobindo Pharma Limited ranks #10 among 199 Indian Nitrofurantoin exporters with a 1.5% market share. The top 3 exporters are MANKIND PHARMA LIMITED ($10.1M), EMCURE PHARMACEUTICALS LIMITED ($2.2M), RECIPHARM PHARMASERVICES PRIVATE LIMITED ($1.2M). Aurobindo Pharma Limited processed 12 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NITROFURANTIONCAPSULES50MG(NITROFURANTOINEAUROBINDOMC50MG, CAPSULES)500'SMFGDFROM BILL OF ENTRY NO5758172DTD08.10.2021NOS | $64.2K | 3 |
| NITROFURANTOIN CAPSULES 100 MG | $50.0K | 1 |
| NITROFURANTOIN CAPSULES 100 MG NITROFURANTOIN CAPSULES USP MACROCRYSTALS 100MG 100'S | $50.0K | 1 |
| NITROFURANTOIN CAPSULES USP (MACROCRYSTALS) 100 MG (100'S) (11424 X 100'S PACKS=1142400 NOS) | $50.0K | 1 |
| NITROFURANTOIN CAPSULES 100MG (50'S) (8040 X 50'S PACKS= 402000 NOS) | $48.0K | 1 |
| NITROFURANTION CAPSULES 50MG(NITROFURANTOINE AUROBINDO MC 50 MG, CAPSULES)500'SNOS | $41.9K | 3 |
| NITROFURANTION CAPSULES 50MG (20'S)(65700PAK)(Nitrofurantoine Aurobindo MC 50 mg, capsules) | $39.6K | 1 |
| NITROFURANTOIN CAPS 100MG-30SQTY: 13835PAKTHE EXPORT ITEM MANUFACTURING D. WITH THE MATERIAL BELONGS TO B.E.NO:5758172DT:08/10/21 |
What Aurobindo Pharma Limited must comply with to export Nitrofurantoin to its top destination countries
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12β15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | INVENTIA HEALTHCARE LIMITED | $600.0K | 12 | 1 | $50.0K |
| 9 | MEDREICH LIMITED | $533.3K | 21 | 4 | $25.4K |
| 10 | AUROBINDO PHARMA LIMITED β | $525.4K | 12 | 4 | $43.8K |
| 11 | AUROBINDO PHARMA LTD | $520.6K | 24 | 4 | $21.7K |
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 264 | 14.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 238 | 13.2% |
| SAHAR AIR | 208 | 11.5% |
| DELHI AIR | 197 | 10.9% |
| NHAVA SHEVA SEA (INNSA1) | 128 | 7.1% |
| JNPT/ NHAVA SHEVA SEA | 93 | 5.1% |
| Bombay Air | 75 | 4.1% |
| Delhi Air | 71 | 3.9% |
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Nitrofurantoin, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Nitrofurantoin β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Nitrofurantoin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile β
81 products Β· $1.1B total trade Β· 18 categories
| MILPHARM LIMITED ALLOGA UKAMBER PARK |
| UNITED KINGDOM |
| $47.3K |
| 2 |
| MILPHARM LIMITED | UNITED KINGDOM | $32.8K | 2 |
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $29.7K | 3 |
| ALLOGA UK AMBER PARK-4UNIT-1 | UNITED KINGDOM | $20.1K | 2 |
Aurobindo Pharma Limited supplies Nitrofurantoin to 14 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by ALLOGA UK (UNITED KINGDOM) and AUROGEN SOUTH AFRICA (PTY) LTD, (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $39.4K |
| 1 |
| NITROFURANTION CAPSULES 50MG (Nitrofurantoin 50 mg hard capsules) 30'S | $36.8K | 2 |
| NITROFURANTOIN CAPSULES 100 MG (NITROFURANTOIN CAPSULES USP (MACROCRYSTALS) 100MG) 100'S | $29.7K | 3 |
Aurobindo Pharma Limited exports 28 distinct Nitrofurantoin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NITROFURANTIONCAPSULES50MG(NITROFURANTOINEAUROBINDOMC50MG, C with 3 shipments worth $64.2K.
Timeline: 10β18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 5 | SANDOZ PRIVATE LIMITED | $500.0K | 10 | 1 | $50.0K |
Aurobindo Pharma Limited ranks #10 among 199 Indian Nitrofurantoin exporters. Average shipment value of $43.8K compared to the market average of $101.4K. The closest competitors by value are INVENTIA HEALTHCARE LIMITED and MEDREICH LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 317+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nitrofurantoin. For current shipment-level data, contact TransData Nexus.